MOLECULAR AND PATHOLOGICAL ANALYSIS OF SPINAL CORD EOSINOPHILIC LESIONS IN ATOPIC MYELITIS

特应性脊髓炎脊髓嗜酸性病变的分子和病​​理学分析

基本信息

  • 批准号:
    12470142
  • 负责人:
  • 金额:
    $ 10.24万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2001
  • 项目状态:
    已结题

项目摘要

1) Clinicolaboratory findings of atopic myelitis with regard to the coexistence of atopic disordersWe conducted a nation-wide survey of atopic myelitis in Japan and then collected 85 cases of this myelitis. Comparison of clinicolaboratory findings between atopic myelitis with and without atopic dermatitis revealed the characteristics of this myelitis as follows ; myelitic patients with atopic dermatitis showed (1)female predominance, (2)younger age of onset, (3)preferential involvement of the cervical cord and (4)less frequent occurrences of sphincter disturbance as comopared to those without atopic dermatitis.2) Immunopathological findings of eosinophilic myelitisFive biopsid cases of eosinophilic myelitis with atopy was collected from all over the country. Immunohistological staining of all biopsied specimens revealed the perivascular lymphocyte cuffings mainly consisted of T cells. In three cases further examined for T cell subsets, CD8 T cells were predominant in the perivascular a … More reas. Moreover, large amounts of eosinophilic cationic protein was found to be deposited in the spinal cord tissues in all cases examined.3) Class II MHC genotypes in atopic myelitisThe associations with DPB1*0501 and DRB1*1501 have been demonstrated in optico-spinal and conventional form of multiple sclerosis, respectively. However, we could not demonstrate either DPB1*0501 or DRB1*1501 association with topic myelitis.4) Treatment of atopic myelitisAlthough a treatment with corticosterods was shown to shorten the duration of acute events due to multiple sclerosis, this treatment was not effective in about two thirds of patients with atopic myelitis. About eighty percentages of patients with this myelitis were successfully treated with plasma exchange. Intravenous immunoglobulin therapy combined with plasma exchange was also useful.The results of this study revealed the presence of atopy-related myeltis in Japanese, in which eosinophils were considered to play a critical role for tissue destruction like other atopic disorders, yet the precise mechanism including the spinal cord inflammation remains to be elucidated. Less
1)特应性近视与特应性疾病共存的临床实验室发现我们在日本进行了一项全国性的特应性近视调查,然后收集了85例这种近视病例。特应性近视伴或不伴特应性皮炎的临床实验室结果比较显示,特应性近视的特征如下:患有特应性皮炎的骨髓炎患者表现出(1)女性占优势,(2)发病年龄较小,(3)颈髓优先受累;(4)与无特应性皮炎的患者相比,括约肌功能障碍的发生率较低。嗜酸性粒细胞性骨髓炎的免疫病理学表现从全国各地收集了5例嗜酸性粒细胞性骨髓炎伴特应性的活检病例。免疫组织化学染色显示血管周围淋巴细胞主要由T细胞组成。在进一步检查T细胞亚群的三个病例中,CD 8 T细胞主要分布在血管周围, ...更多信息 是的。此外,大量的嗜酸性阳离子蛋白被发现沉积在脊髓组织中,在所有的情况下检查。3)II类MHC基因型在特应性骨髓炎与DPB 1 *0501和DRB 1 *1501的关联已被证明在视脊髓和传统形式的多发性硬化症,分别。然而,我们不能证明DPB 1 *0501或DRB 1 *1501与特应性近视的相关性。4)特应性近视的治疗尽管用皮质类固醇治疗显示出缩短了由于多发性硬化引起的急性事件的持续时间,但这种治疗对约三分之二的特应性近视患者无效。约80%的患者成功地进行了血浆置换治疗。静脉注射免疫球蛋白治疗结合血浆exploration.The研究结果显示,存在特应性相关的脊髓炎在日本,其中嗜酸性粒细胞被认为是发挥关键作用的组织破坏像其他特应性疾病,但确切的机制,包括脊髓炎症仍有待澄清。少

项目成果

期刊论文数量(74)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Horiuchi I, Yamasaki K, Osoegawa M, Ohyagi Y, Okayama A, Kurokawa T, Yamada T, Kira J: "Acute myelitis after asthma attacks with onset after puberty"J Neurol Neurosurg Psychiatry. 68. 665-668 (2000)
Horiuchi I、Yamasaki K、Osoekawa M、Ohyagi Y、Okayama A、Kurokawa T、Yamada T、Kira J:“青春期后发作的哮喘发作后的急性脊髓炎”J Neurol Neurosurg Psychiatry。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
吉良潤一: "別刷・医学のあゆみ 21世紀の神経免疫学"医試薬出版株式会社. 207 (2001)
吉良纯一:《重印:医学史:21世纪的神经免疫学》谏药出版有限公司207(2001)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kira J, et al.: "Juvenile musclar atrophy of distal upper extremity (Hirayama disease) associated with atopy"J. Neuro. Neurosurg. Psychiatry. 70. 798-801 (2001)
Kira J 等人:“与特应性相关的青少年上肢远端肌肉萎缩(平山病)”J.
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Wu X-M, et al: "Flow cytometric differentiation of Asian and Western types of multiple sclerosis (MS), HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and hyperIgEaemic myelitis by analysis of memory CD4 positive T cell subsets and NK
Wu X-M 等人:“通过分析记忆 CD4 阳性 T 细胞亚群和分析,流式细胞术区分亚洲和西方类型的多发性硬化症 (MS)、HTLV-1 相关脊髓病/热带痉挛性截瘫 (HAM/TSP) 和高 IgE 性脊髓炎
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
呉暁牧 他: "炎症性中枢神経疾患におけるIL-5、IL-13の検討"神経免疫学. 9. 54-55 (2001)
吴晓木等:“炎症性中枢神经系统疾病中IL-5和IL-13的检查”《神经免疫学》9. 54-55 (2001)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KIRA Jun-ichi其他文献

KIRA Jun-ichi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KIRA Jun-ichi', 18)}}的其他基金

Developing a cell transplantation therapy for chronic multiple sclerosis by using Schwann cells induced from mesenchymal stem cells
利用间充质干细胞诱导的雪旺细胞开发治疗慢性多发性硬化症的细胞移植疗法
  • 批准号:
    25670423
  • 财政年份:
    2013
  • 资助金额:
    $ 10.24万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Connexin astrocytopathy in the pathogenesis of demyelination in concentric sclerosis and multiple sclerosis
连接蛋白星形细胞病在同心硬化症和多发性硬化症脱髓鞘发病机制中的作用
  • 批准号:
    23659459
  • 财政年份:
    2011
  • 资助金额:
    $ 10.24万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Development of molecular targeted therapy of multiple sclerosis on the basis of membrane protein microarray analysis and gene interactions
基于膜蛋白微阵列分析和基因相互作用开发多发性硬化症分子靶向治疗
  • 批准号:
    22390178
  • 财政年份:
    2010
  • 资助金额:
    $ 10.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Role of IL-17 producing T cells in opticospinal multiple sclerosis
产生 IL-17 的 T 细胞在视脊髓多发性硬化症中的作用
  • 批准号:
    18390261
  • 财政年份:
    2006
  • 资助金额:
    $ 10.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of an animal model of opticospinal form of multiple sclerosis using the HLA-DP5 transgenic mice.
使用 HLA-DP5 转基因小鼠开发视脊髓形式的多发性硬化症动物模型。
  • 批准号:
    14370209
  • 财政年份:
    2002
  • 资助金额:
    $ 10.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Identification of a specific autoantigen in opticospinal form of multiple sclerosis based on the HLA-DPB1 binding motif
基于 HLA-DPB1 结合基序鉴定多发性硬化症视脊髓形式的特异性自身抗原
  • 批准号:
    12557060
  • 财政年份:
    2000
  • 资助金额:
    $ 10.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Induction of chronic inflammatory myelopathy in rats infected with recombinant HTLV-I
重组HTLV-I感染大鼠慢性炎症性脊髓病的诱导
  • 批准号:
    10557062
  • 财政年份:
    1998
  • 资助金额:
    $ 10.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Establishment of a polyreactive T cell clone from Asian type multiple sclerosis patients and identification of the responsible antigens
亚洲型多发性硬化症患者多反应性 T 细胞克隆的建立及相关抗原的鉴定
  • 批准号:
    10470154
  • 财政年份:
    1998
  • 资助金额:
    $ 10.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of T cell epitope in Asian type multiple sclerosis
亚洲型多发性硬化症T细胞表位分析
  • 批准号:
    08670712
  • 财政年份:
    1996
  • 资助金额:
    $ 10.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Elucidation of atopic dermatitis pathology through nucleic acid-independent single-cell microbiome analysis
通过不依赖核酸的单细胞微生物组分析阐明特应性皮炎病理学
  • 批准号:
    23H02930
  • 财政年份:
    2023
  • 资助金额:
    $ 10.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Elucidation of the mechanism related to dental metal allergy to exacerbation of atopic dermatitis
阐明牙科金属过敏与特应性皮炎恶化的相关机制
  • 批准号:
    23K16062
  • 财政年份:
    2023
  • 资助金额:
    $ 10.24万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Skin probiotics to treat atopic dermatitis
皮肤益生菌治疗特应性皮炎
  • 批准号:
    10760367
  • 财政年份:
    2023
  • 资助金额:
    $ 10.24万
  • 项目类别:
Investigation of Filaggrin Gene Mutations among Latinx patients with Atopic Dermatitis
拉丁裔特应性皮炎患者丝聚蛋白基因突变的调查
  • 批准号:
    10740811
  • 财政年份:
    2023
  • 资助金额:
    $ 10.24万
  • 项目类别:
Genetic analysis of the pathogenesis of atopic dermatitis focusing on the allergic sensitivity of NC mice.
以NC小鼠过敏敏感性为重点的特应性皮炎发病机制的遗传分析。
  • 批准号:
    23K05600
  • 财政年份:
    2023
  • 资助金额:
    $ 10.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clarification of the pathogenic mechanism of atopic dermatitis-associated brain inflammation
阐明特应性皮炎相关脑炎症的发病机制
  • 批准号:
    23KF0068
  • 财政年份:
    2023
  • 资助金额:
    $ 10.24万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Living systematic review and network meta-analysis of systemic immunomodulatory treatments for atopic dermatitis
特应性皮炎全身免疫调节治疗的活体系统评价和网络荟萃分析
  • 批准号:
    485092
  • 财政年份:
    2023
  • 资助金额:
    $ 10.24万
  • 项目类别:
    Operating Grants
Patient engagement in atopic dermatitis (eczema) guidelines and a model for future trustworthy, patient-centred guidelines
患者参与特应性皮炎(湿疹)指南以及未来值得信赖、以患者为中心的指南模型
  • 批准号:
    485111
  • 财政年份:
    2023
  • 资助金额:
    $ 10.24万
  • 项目类别:
    Operating Grants
Living systematic review and network meta-analysis of systemic immunomodulatory treatments for atopic dermatitis
特应性皮炎全身免疫调节治疗的活体系统评价和网络荟萃分析
  • 批准号:
    485106
  • 财政年份:
    2023
  • 资助金额:
    $ 10.24万
  • 项目类别:
    Operating Grants
Defining the role of IL-18 in atopic dermatitis
定义 IL-18 在特应性皮炎中的作用
  • 批准号:
    10681016
  • 财政年份:
    2023
  • 资助金额:
    $ 10.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了